Exact Mass: 315.0500008

Exact Mass Matches: 315.0500008

Found 48 metabolites which its exact mass value is equals to given mass value 315.0500008, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

clonazepam

clonazepam

C15H10ClN3O3 (315.041066)


N - Nervous system > N03 - Antiepileptics > N03A - Antiepileptics > N03AE - Benzodiazepine derivatives C78272 - Agent Affecting Nervous System > C29756 - Sedative and Hypnotic > C1012 - Benzodiazepine D018377 - Neurotransmitter Agents > D018682 - GABA Agents > D018757 - GABA Modulators C78272 - Agent Affecting Nervous System > C264 - Anticonvulsant Agent C78272 - Agent Affecting Nervous System > C28197 - Antianxiety Agent D002491 - Central Nervous System Agents > D000927 - Anticonvulsants

   

Clonazepam

5-(2-Chloro-phenyl)-7-nitro-1,3-dihydro-benzo[e][1,4]diazepin-2-one

C15H10ClN3O3 (315.041066)


An anticonvulsant used for several types of seizures, including myotonic or atonic seizures, photosensitive epilepsy, and absence seizures, although tolerance may develop. It is seldom effective in generalized tonic-clonic or partial seizures. The mechanism of action appears to involve the enhancement of gamma-aminobutyric acid receptor responses. [PubChem] N - Nervous system > N03 - Antiepileptics > N03A - Antiepileptics > N03AE - Benzodiazepine derivatives C78272 - Agent Affecting Nervous System > C29756 - Sedative and Hypnotic > C1012 - Benzodiazepine D018377 - Neurotransmitter Agents > D018682 - GABA Agents > D018757 - GABA Modulators C78272 - Agent Affecting Nervous System > C264 - Anticonvulsant Agent C78272 - Agent Affecting Nervous System > C28197 - Antianxiety Agent D002491 - Central Nervous System Agents > D000927 - Anticonvulsants

   

4-Nitrophenyl beta-D-glucopyranosiduronic acid

3,4,5-trihydroxy-6-(4-nitrophenoxy)oxane-2-carboxylic acid

C12H13NO9 (315.0590288)


   
   

Methyl 3-bromo-4-[3-(dimethylamino)propoxy]benzoate

Methyl 3-bromo-4-[3-(dimethylamino)propoxy]benzoate

C13H18BrNO3 (315.0469978)


   

2-(3-BROMO-PHENYL)-N-(2,2-DIMETHOXY-ETHYL)-N-METHYL-ACETAMIDE

2-(3-BROMO-PHENYL)-N-(2,2-DIMETHOXY-ETHYL)-N-METHYL-ACETAMIDE

C13H18BrNO3 (315.0469978)


   
   

2-NITRO-4-(TRIFLUOROMETHYLSULFONYL)ANLILINE

2-NITRO-4-(TRIFLUOROMETHYLSULFONYL)ANLILINE

C13H18BrNO3 (315.0469978)


   

tert-Butyl (S)-2-(4-bromo-1H-imidazol-2-yl)pyrrolidine-1-carboxylate

tert-Butyl (S)-2-(4-bromo-1H-imidazol-2-yl)pyrrolidine-1-carboxylate

C12H18BrN3O2 (315.0582308)


   

7-Anilino-4-hydroxy-2-naphthalenesulfonic acid

7-Anilino-4-hydroxy-2-naphthalenesulfonic acid

C16H13NO4S (315.05652580000003)


   

4-Nitrophenyl β-D-glucopyranosiduronic acid

4-Nitrophenyl beta-D-glucopyranosiduronic acid

C12H13NO9 (315.0590288)


   

7-Anilino-1-naphthol-3-sulfonic Acid

7-Anilino-1-naphthol-3-sulfonic Acid

C16H13NO4S (315.05652580000003)


   

disodium,1-(N-benzylcarbamimidoyl)-2-phosphonatoguanidine,hydrate

disodium,1-(N-benzylcarbamimidoyl)-2-phosphonatoguanidine,hydrate

C9H12N5Na2O3P (315.0473132)


   

2-bromo-N,N-diethyl-4,5-dimethoxybenzamide

2-bromo-N,N-diethyl-4,5-dimethoxybenzamide

C13H18BrNO3 (315.0469978)


   

5-[ISOCYANO-(TOLUENE-4-SULFONYL)-METHYL]-BENZO[1,3]DIOXOLE

5-[ISOCYANO-(TOLUENE-4-SULFONYL)-METHYL]-BENZO[1,3]DIOXOLE

C16H13NO4S (315.05652580000003)


   

ETHYL 2-(2-[3-(TRIFLUOROMETHYL)PHENYL]-1,3-THIAZOL-4-YL)ACETATE

ETHYL 2-(2-[3-(TRIFLUOROMETHYL)PHENYL]-1,3-THIAZOL-4-YL)ACETATE

C14H12F3NO2S (315.0540808)


   

3-[4-[(4-METHYLPHENYL)THIO]-3-NITROPHENYL]ACRYLIC ACID

3-[4-[(4-METHYLPHENYL)THIO]-3-NITROPHENYL]ACRYLIC ACID

C16H13NO4S (315.05652580000003)


   

3-[2-[(4-METHYLPHENYL)THIO]-5-NITROPHENYL]ACRYLIC ACID

3-[2-[(4-METHYLPHENYL)THIO]-5-NITROPHENYL]ACRYLIC ACID

C16H13NO4S (315.05652580000003)


   

p-Nitrophenyl-beta-D-glucuronide

(2S,3S,4S,5R,6R)-3,4,5-Trihydroxy-6-(4-nitrophenoxy)tetrahydro-2H-pyran-2-carboxylic acid

C12H13NO9 (315.0590288)


   

(E)-1-TERT-BUTYL4-ETHYL2,3,6,7-TETRAHYDROAZEPINE-1,4-DICARBOXYLATE

(E)-1-TERT-BUTYL4-ETHYL2,3,6,7-TETRAHYDROAZEPINE-1,4-DICARBOXYLATE

C13H18BrNO3 (315.0469978)


   

Ethyl 4-methyl-2-[4-(trifluoromethyl)phenyl]-1,3-thiazole-5-carboxylate

Ethyl 4-methyl-2-[4-(trifluoromethyl)phenyl]-1,3-thiazole-5-carboxylate

C14H12F3NO2S (315.0540808)


   

Carbamic acid, [(1R)-1-(3-bromophenyl)-2-hydroxyethyl]-, 1,1-dimethylethyl ester (9CI)

Carbamic acid, [(1R)-1-(3-bromophenyl)-2-hydroxyethyl]-, 1,1-dimethylethyl ester (9CI)

C13H18BrNO3 (315.0469978)


   
   

5-[[2,5-Dimethyl-1-(3-pyridinyl)-1H-pyrrol-3-yl]methylene]-2-thioxo-4-thiazolidinone

5-[[2,5-Dimethyl-1-(3-pyridinyl)-1H-pyrrol-3-yl]methylene]-2-thioxo-4-thiazolidinone

C15H13N3OS2 (315.0500008)


   

3-[[Oxo(thiophen-2-yl)methyl]amino]-2-benzofurancarboxylic acid ethyl ester

3-[[Oxo(thiophen-2-yl)methyl]amino]-2-benzofurancarboxylic acid ethyl ester

C16H13NO4S (315.05652580000003)


   
   

2-Methylcarbamoyl-3-(4-phosphonooxy-phenyl)-cyclopropanecarboxylic acid

2-Methylcarbamoyl-3-(4-phosphonooxy-phenyl)-cyclopropanecarboxylic acid

C12H14NO7P (315.05078640000005)


   

3,5-dihydroxy-2-(4-hydroxy-3-methoxyphenyl)-4-oxo-4H-chromen-7-olate

3,5-dihydroxy-2-(4-hydroxy-3-methoxyphenyl)-4-oxo-4H-chromen-7-olate

C16H11O7- (315.0504756)


   

3-O-methyltricetin(1-)

3-O-methyltricetin(1-)

C16H11O7- (315.0504756)


The conjugate base of 3-O-methyltricetin arising from selective deprotonation of the 7-OH position; major species at pH 7.3.

   

3,4,5-Trihydroxy-3-methoxyflavon-7-olate

3,4,5-Trihydroxy-3-methoxyflavon-7-olate

C16H11O7- (315.0504756)


The conjugate base of 3,4,5,7-tetrahydroxy-3-methoxyflavone arising from selective deprotonation of the 7-hydroxy group; major species at pH 7.3.

   
   

5,7-Dihydroxy-2-(4-hydroxyphenyl)-8-methoxy-4-oxochromen-3-olate

5,7-Dihydroxy-2-(4-hydroxyphenyl)-8-methoxy-4-oxochromen-3-olate

C16H11O7- (315.0504756)


   

2,5,8-Trihydroxy-1,3-dimethoxyanthraquinone

2,5,8-Trihydroxy-1,3-dimethoxyanthraquinone

C16H11O7- (315.0504756)


   

1,5,7-trihydroxy-6,8-dimethoxyanthraquinone

1,5,7-trihydroxy-6,8-dimethoxyanthraquinone

C16H11O7- (315.0504756)


   

2,3,4,5-Tetrafluoro-6-(3-methoxyanilino)benzoic acid

2,3,4,5-Tetrafluoro-6-(3-methoxyanilino)benzoic acid

C14H9F4NO3 (315.0518532)


   

4-(4-chlorophenyl)-3-(2-phenylethyl)-1H-1,2,4-triazole-5-thione

4-(4-chlorophenyl)-3-(2-phenylethyl)-1H-1,2,4-triazole-5-thione

C16H14ClN3S (315.0596914)


   

2-amino-7-methyl-4-(5-nitro-2-furanyl)-5-oxo-4H-pyrano[3,2-c]pyran-3-carbonitrile

2-amino-7-methyl-4-(5-nitro-2-furanyl)-5-oxo-4H-pyrano[3,2-c]pyran-3-carbonitrile

C14H9N3O6 (315.04913339999996)


   

N-[3-(1,3-benzothiazol-2-yl)-5,6-dihydro-4H-thieno[2,3-c]pyrrol-2-yl]acetamide

N-[3-(1,3-benzothiazol-2-yl)-5,6-dihydro-4H-thieno[2,3-c]pyrrol-2-yl]acetamide

C15H13N3OS2 (315.0500008)


   

5-Nitro-2-furancarboxylic acid (5-phenyl-1,3,4-oxadiazol-2-yl)methyl ester

5-Nitro-2-furancarboxylic acid (5-phenyl-1,3,4-oxadiazol-2-yl)methyl ester

C14H9N3O6 (315.04913339999996)


   

2-[(3-Cyano-6-cyclopropyl-4-thiophen-2-yl-2-pyridinyl)thio]acetamide

2-[(3-Cyano-6-cyclopropyl-4-thiophen-2-yl-2-pyridinyl)thio]acetamide

C15H13N3OS2 (315.0500008)


   
   

2-thiophen-2-ylethyl (Z)-2-cyano-3-(3,4-dihydroxyphenyl)prop-2-enoate

2-thiophen-2-ylethyl (Z)-2-cyano-3-(3,4-dihydroxyphenyl)prop-2-enoate

C16H13NO4S (315.05652580000003)


   

4-nitrophenyl beta-D-glucuronide

4-nitrophenyl beta-D-glucuronide

C12H13NO9 (315.0590288)


A beta-D-glucosiduronic acid having a 4-nitrophenyl substituent at the anomeric position.

   

isorhamnetin(1-)

isorhamnetin(1-)

C16H11O7 (315.0504756)


A flavonoid oxoanion that is the conjugate base of isorhamnetin, arising from the deprotonation of the 7-hydroxy group; major species at pH 7.3.

   

(1R,2S)-VU0155041

(1R,2S)-VU0155041

C14H15Cl2NO3 (315.04289400000005)


(1R,2S)-VU0155041, Cis regioisomer of VU0155041, is a partial mGluR4 agonist with an EC50 of 2.35 μM.

   

2-TEDC

2-TEDC

C16H13NO4S (315.05652580000003)


2-TEDC is a potent inhibitor of 5-, 12-, and 15-lipoxygenase with IC50 values of 0.09 μM, 0.013 μM and 0.5 μM, respectively. 2-TEDC can be used for the research of atheroscrelosi[1].

   

VU0155041

VU0155041

C14H15Cl2NO3 (315.04289400000005)


VU0155041 is a potent, selective positive allosteric modulator (PAM) of mGluR4, with EC50s of 798 nM and 693 nM for human and rat mGluR4, respectively. VU0155041 has potential for the research of Parkinson's disease (PD)[1].

   

3,5-dioxa-11-azahexacyclo[9.9.2.0²,⁶.0⁸,²¹.0¹⁴,²².0¹⁵,²⁰]docosa-1,6,8(21),9,14(22),15(20),16,18-octaene-12,13-dione

3,5-dioxa-11-azahexacyclo[9.9.2.0²,⁶.0⁸,²¹.0¹⁴,²².0¹⁵,²⁰]docosa-1,6,8(21),9,14(22),15(20),16,18-octaene-12,13-dione

C19H9NO4 (315.0531554)